Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study

1. González-Martín, A.
2. Chung, H.C.
3. Saada-Bouzid, E.
4. Yanez, E.
5. Senellart, H.
6. Cassier, P.A.
7. Basu, B.
8. Corr, B.R.
9. Girda, E.
10. Dutcus, C.
11. Okpara, C.E.
12. Ghori, R.
13. Jin, F.
14. Groisberg, R.
15. Lwin, Z.